Shots: Abbott and Sanofi team up to develop tools integrating their blood sugar tracking and insulin delivery technologies to help diabetes patients in managing their conditions The non-exclusive agreement will combine Abbott’s FreeStyle Libre continuous glucose monitoring system with Sanofi’s connected insulin pens, apps and cloud software currently in development, allowing patients & doctors to […]Read More
Shots: The companies jointly enter into P-I trial evaluating the clinical benefits, combining immune stimulator, Immuntep’s eftilagimod alpha (“efti” or “IMP321”), with Merck and Pfizer’s avelumab. Alliances will jointly develop and commercialize avelumab The Institute of Clinical Cancer Research, will sponsor the trial, conducted & involved under ongoing INSIGHT clinical study evaluating P-II dose of […]Read More
Shots: Mylan to get exclusive commercialization rights of the product in >100 countries, including Africa, Asia, the Middle East, the Commonwealth of Independent States (CIS) and Latin America. Mylan plans to launch Mylan HIV Self-Test in global markets in 2019 CE-Marked in-vitro HIV rapid diagnostic tests allow individuals to detect presence or absence of HIV […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
